Kuros Biosciences Forecast, price target & analysts
Why the stock moved Beta
Kuros Biosciences Target price 2026 - Analyst rating & recommendation
Kuros Biosciences Classifications & Recommendation
Kuros Biosciences Price Target
| Target Price | CHF33.66 |
| Price | CHF18.85 |
| Potential |
78.57%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Kuros Biosciences 2027 .
The average Kuros Biosciences target price is CHF33.66.
This is
78.57%
register free of charge
CHF39.90
111.67%
register free of charge
CHF32.32
71.46%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend Kuros Biosciences to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Kuros Biosciences stock has an average upside potential 2027 of
78.57%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million CHF | 122.05 | 186.32 |
| 71.51% | 52.66% | |
| EBITDA Margin | 6.99% | 10.62% |
| 590.74% | 51.95% |
6 Analysts have issued a sales forecast Kuros Biosciences 2026 . The average Kuros Biosciences sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Kuros Biosciences EBITDA forecast 2026. The average Kuros Biosciences EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 0.05 | 0.23 |
| 155.56% | 360.00% | |
| P/E | 80.51 | |
| EV/Sales | 3.83 |
6 Analysts have issued a Kuros Biosciences forecast for earnings per share. The average Kuros Biosciences EPS is
This results in the following potential growth metrics and future valuations:
Kuros Biosciences...
Current Kuros Biosciences Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BAADER EUROPE |
Locked
➜
Locked
|
Locked | Aug 20 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| BAADER EUROPE |
Locked
➜
Locked
|
Locked | Jul 10 2026 |
| BAADER EUROPE |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jul 08 2026 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Oct 15 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BAADER EUROPE:
Locked
➜
Locked
|
Aug 20 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
BAADER EUROPE:
Locked
➜
Locked
|
Jul 10 2026 |
|
Locked
BAADER EUROPE:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jul 08 2026 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Oct 15 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
